A virally inactivated functional growth factor preparation from human platelet concentrates

Vox Sanguinis

Volumn 97, Issue 2, 2009, Pages 119-128

  Su, C Y ^a   Kuo, Y P ^a   Lin, Y C ^b   Huang, C T ^b   Tseng, Y H ^c   Burnouf, T ^b,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c Gwo Wei Dental Implant Center   (Taiwan)

^d HUMAN PROTEIN PROCESS SCIENCES   (France)

Author keywords

Cell cultures; Growth factors; MTS assay; Platelet; Viral inactivation

Indexed keywords

EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CHROMATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FIBROBLAST; FILTRATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS INACTIVATION;

ANIMALS; BLOOD PLATELETS; CELL LINE; CELL PROLIFERATION; CELL TRANSPLANTATION; CHEMICAL FRACTIONATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RABBITS; REGENERATIVE MEDICINE;

EID: 68249133730     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01180.x     Document Type: Article

References (52)

1. Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K : No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007 92 : 1208 1215
2. Gregory CA, Reyes E, Whitney MJ, Spees JL : Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs. Stem Cells 2006 24 : 2232 2243
3. Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, DeArmond SJ, Prusiner SB : Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 1999 96 : 15137 15142
4. Johansson L, Klinth J, Holmqvist O, Ohlson S : Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology 2003 42 : 67 74
5. Cenni E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N : Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 2005 76 : 323 328
6. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P : Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003 24 : 3095 3100
7. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D : Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007 47 : 1436 1446
8. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ : Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005 205 : 228 236
9. Kazemnejad S, Allameh A, Gharehbaghian A, Soleimani M, Amirizadeh N, Jazayeri M : Efficient replacing of fetal bovine serum with human platelet releasate during propagation and differentiation of human bone-marrow-derived mesenchymal stem cells to functional hepatocyte-like cells. Vox Sang 2008 95 : 149 158
10. Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M : Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2008 2 : 742 781
11. Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A, Mico C, Rambaldi A, Golay J, Introna M : Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 2007 40 : 785 791
12. Mirabet V, Solves P, Minana MD, Encabo A, Carbonell-Uberos F, Blanquer A, Roig R : Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank 2008 9 : 1 10
13. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR : Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 85 : 638 646
14. Whitman DH, Berry RL, Green DM : Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997 55 : 1294 1299
15. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT : Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004 91 : 4 15 (Pubitemid 38111215)
16. Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A : Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 2006 38 : 174 187
17. Borzini P, Mazzucco L : Platelet gels and releasates. Curr Opin Hematol 2005 12 : 473 479
18. Marx RE : Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004 62 : 489 496
19. Bolander ME : Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992 200 : 165 170
20. Schliephake H : Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002 31 : 469 484
21. Frechette JP, Martineau I, Gagnon G : Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005 84 : 434 439
22. Snyder EL, Calhoun BC : Topical platelet growth factor therapy of lotions and potions. Transfusion 2001 41 : 1186 1189
23. Martinez-Zapata MJ, Marti-Carvajal A, Sola I, Bolibar I, Angel Exposito J, Rodriguez L, Garcia J : Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion 2009 49 : 44 56
24. Steed DL : Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 2006 117 : 143S 9S discussion 50S 51S
25. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH : Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999 7 : 335 346
26. Cooke JW, Sarment DP, Whitesman LA, Miller SE, Jin Q, Lynch SE, Giannobile WV : Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng 2006 12 : 1441 1450
27. Sarment DP, Cooke JW, Miller SE, Jin Q, McGuire MK, Kao RT, McClain PK, McAllister BS, Lynch SE, Giannobile WV : Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol 2006 33 : 135 140
28. Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE : Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 2008 90 : 48 54
29. Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F : Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 2007 11 : 1 150, iii iv
30. Bishop GB, Einhorn TA : Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 2007 31 : 721 727
31. Anitua E, Sanchez M, Orive G, Andia I : The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007 28 : 4551 4560
32. Burnouf T, Tseng YH, Kuo YP, Su CY : Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Transfusion 2008 48 : 1090 1098
33. Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M : A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Transfusion 2006 46 : 2100 2108
34. Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M : A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system. Vox Sang 2006 91 : 56 62
35. Su CY, Kuo YP, Nieh HL, Tseng YH, Burnouf T : Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008 48 : 2414 2420
36. Su CY, Chiang CC, Lai WF, Lin KW, Burnouf T : Platelet-derived growth factor-AB and transforming growth factor-beta1 in platelet gels activated by single-donor human thrombin. Transfusion 2004 44 : 945
37. Michalski C, Bal F, Burnouf T, Goudemand M : Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma. Vox Sang 1988 55 : 202 210
38. Burnouf T, Radosevich M : Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000 14 : 94 110
39. Klein HG : Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005 257 : 224 237
40. WHO : Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. http://www.WHO.int. Geneva 2003
41. Horowitz B, Bonomo R, Prince AM, Chin SN, Brotman B, Shulman RW : Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992 79 : 826 831
42. Piet MP, Chin S, Prince AM, Brotman B, Cundell AM, Horowitz B : The use of tri (n-butyl) phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion 1990 30 : 591 598
43. Burnouf T, Goubran H, Radosevich M, El-Ekiaby M : Preparation and viral inactivation of cryoprecipitate in blood banks in resource-limited countries. ISBT Sci Series 2007 2 : 121 128
44. Burnouf T, Goubran HA, Radosevich M, El-Ekiaby M : Solvent-detergent viral inactivation of minipools of plasma for transfusion, cryoprecipitate and cryo-poor plasma in single-use bag systems. Transfus Clin Biol 2008 15 : 129 134
45. Aubin JT, Defer C, Vidaud M, Maniez Montreuil M, Flan B : Large-scale screening for human parvovirus B19 DNA by PCR. Application to the quality control of plasma for fractionation. Vox Sang 2000 78 : 7 12
46. WHO : Recommendations for the production, quality control and regulation of plasma for fractionation. http://www.who.int/bloodproducts 2005
47. Solheim BG, Rollag H, Svennevig JL, Arafa O, Fosse E, Bergerud U : Viral safety of solvent/detergent-treated plasma. Transfusion 2000 40 : 84 90
48. Burnouf T, Radosevich M, El-Ekiaby M, Satoh S, Sato T, Amin SN, Savidge GF, Goubran HA : Nanofiltration of single plasma donations: feasibility study. Vox Sang 2003 84 : 111 119
49. Niederkorn JY, Meyer DR, Ubelaker JE, Martin JH : Ultrastructural and immunohistological characterization of the SIRC corneal cell line. In Vitro Cell Dev Biol 1990 26 : 923 930
50. Pancholi S, Tullo A, Khaliq A, Foreman D, Boulton M : The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. Graefes Arch Clin Exp Ophthalmol 1998 236 : 1 8
51. Haber M, Cao Z, Panjwani N, Bedenice D, Li WW, Provost PJ : Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and keratocytes: implications for wound healing. Vet Ophthalmol 2003 6 : 211 217
52. Kruse FE, Tseng SC : Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 1993 34 : 1963 1976